Dr. Reddy's Laboratories is a pharmaceutical company. Co.'s operations are organzied in three business segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes branded and unbranded prescription and over-the-counter drug products business. The PSAI segment consists of Co.'s Active Pharmaceutical Ingredients business and its Custom Pharmaceutical Services business. The Proprietary Products segment consists of Co.'s Generic Biopharmaceuticals business, its New Chemical Entities business, its Differentiated Formulations business and its dermatology focused specialty business operated through Promius Pharma.
RDY — Key Stats (updated Monday, March 3, 10:24 AM)
Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Service. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20
minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.